Visible Light‐Mediated Photocatalytic Dearomative Hydroxylation of 2‐aryl‐3‐aryl/Alkyl Indoles
Asian Journal of Organic Chemistry · 2026-04 · 15 (4)
DOI: 10.1002/ajoc.70391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Organic Chemistry, online erschienen am 15.04.2026. Verfasst von Shubham Choudhari und 2 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
We have developed a visible‐light‐driven photocatalytic protocol for the efficient synthesis of 3‐hydroxyindolenines under mild reaction conditions. The transformation proceeds via a photocatalytic oxidative process mediated by chlorophyll, which functions as a sustainable, metal‐free, and environmentally benign photocatalyst. Upon irradiation with visible light, chlorophyll is photoexcited to its reactive excited state, enabling effective single‐electron transfer (SET) and/or energy‐transfer pathways that promote the oxidative functionalization of the indole framework. This reaction facilitates selective oxidation at the C3 position of indole substrates, leading to the formation of 3‐hydroxyindolenine derivatives.
Förderung
- Council of Scientific and Industrial Research, India
Zitieren
APA
Choudhari, S., Yadav, S. K., & Yadav, P. P. (2026). Visible Light‐Mediated Photocatalytic Dearomative Hydroxylation of 2‐aryl‐3‐aryl/Alkyl Indoles. Asian Journal of Organic Chemistry, 15(4). https://doi.org/10.1002/ajoc.70391
Vancouver
Choudhari S, Yadav SK, Yadav PP. Visible Light‐Mediated Photocatalytic Dearomative Hydroxylation of 2‐aryl‐3‐aryl/Alkyl Indoles. Asian Journal of Organic Chemistry. 2026;15(4). doi:10.1002/ajoc.70391
BibTeX
@article{Choudhari2026,
author = {Choudhari, Shubham and Yadav, Suchit Kumar and Yadav, Prem P.},
title = {Visible Light‐Mediated Photocatalytic Dearomative Hydroxylation of 2‐aryl‐3‐aryl/Alkyl Indoles},
journal = {Asian Journal of Organic Chemistry},
year = {2026},
volume = {15},
number = {4},
doi = {10.1002/ajoc.70391}
}
EUVIMED